(206) 812-9988
  Brown-Grant K. The iodide concentrating mechanism of the mammary gland. J Physiol. 1957;135:644–654. Eskin BA. Iodine metabolism and breast cancer. Trans NY Acad Sci 1970;32:911–947. Eskin BA, Bartuska DG, Dunn MR, Jacob G, Drafman MB. Mammary gland dysplasia in iodine deficiency. Studies in rats. JAMA 1967;200:691. https://www.ncbi.nlm.nih.gov/pubmed/?term=eskin+b+iodine Eskin BA. Iodine and mammary cancer Adv Exp Med Biol 1977;91:293–304 Eskin BA, Grotkowski CE, Connolly CP, Ghent WR. Different tissue responses for iodine and iodide        in rat thyroid and mammary glands. Biol Trace Elem Res 1995:49:9-19. Smyth PP. Thyroid disease and breast cancer. JEndocrinol Invest 1993;16:396-401. Eskin BA, Grotkowski CE, Connolly CP, Ghent WR. Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biol Trace Elem Res 1995:49:9-19. Lemon HM. Endocrine influences on human mammary cancer formation. A critique. Cancer. 1969;23:781-790. [1]Lemon HM. Pathophysiologic considerations in the treatment of menopausal patients withoestrogens; the role of oestriol in the prevention of mammary carcinoma. Acta Endocrinol Suppl (Copenh). 1980;233:17-27. Lemon H. Oestriol and prevention of breast cancer. Lancet. 1973;1:546-547. Lemon HM, Heidel JW, Rodriguez-Sierra JF. Principles of breast cancer prevention. Paper presented at: Annual Meeting of the AACR, 1991. Follingstad A. Estriol, the forgotten estrogen? JAMA. 1978;239:29-30. Wright JV. Bio-Identical Hormone Replacement: Selected Observations from 23 Years of Clinical and Laboratory Practice. Annals of the New York Academy of Sciences 2005 December 2005;1057:506-524 Aceves C, Anguiano B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):189-96. Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A, Godbole MM. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem. 2006 Jul 14;281(28):19762-71 Arroyo-Helguera O, Anguiano B, Delgado G, Aceves C. Uptake and anti-proliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocr Relat Cancer. 2006 Dec;13(4):1147-58. Aceves C, García-Solís P, Arroyo-Helguera O, Vega-Riveroll L, Delgado G, Anguiano B. Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone   (6-IL) and peroxisome proliferator-activated receptors (PPAR). Mol Cancer 2009 Jun 6;8:33. Gärtner R, Rank P, Ander B. The role of iodine and delta-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells. Hormones (Athens). 2010 Jan-Mar;9(1):60-6. Aceves C, Anguiano B, Delgado G The Extrathyronine Actions of Iodine as Antioxidant, Apoptotic, and Differentiation Factor in Various Tissues Thyroid 2013 Altman Y et al. The Potential of Iodine for improving breast cancer diagnosis and treatment. Med Hypotheses 2013;80(1);94-98 Pool VL, McCabe CJ. Iodide transport and breast cancer J Endocrinol 2015;227(1):R1-R2 Nava-Villalba M, Aceves C. 6-iodolactone, key mediator of antitumoral properties of iodine    Prostaglandins Other Lipid Mediat 2014 Aug;112:27-33 https://www.deadiversion.usdoj.gov/fed_regs/rules/2007/fr0702.htm
Iodine Treats Breast Cancer, Overwhelming Evidence
Rösner H, Torremante P, Möller W, Gärtner R. Antiproliferative/cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGF-signaling, but evidence for apoptosis. Exp Clin Endocrinol Diabetes. 2010 Jul;118(7):410-9